Abstract
Background: Cerebral microbleeds (CMBs) is frequently observed in patients with stroke and Alzheimer’s disease. We reported the prevalence and risk factors of CMBs in patients with Parkinson’s disease (PD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
